chartexchange

TENX
Tenax Therapeutics, Inc.
stockNASDAQ

At CloseNov 6, 2026 3:59:01 PM EST
1.68USD+3.374%(+0.05)789,279
Pre-marketNov 6, 2026 9:15:30 AM EST
1.65USD+1.227%(+0.02)
After-hoursNov 6, 2026 4:37:30 PM EST
1.6551USD-1.774%(-0.0299)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Anthony DiTonno
HQ
Chapel Hill, NC, USA
Previous Close
$1.63
Beta
1.10
52-Week High
$19.40 2026-07-09
52-Week Low
$1.31 2026-08-10
SMA 50
$1.81
SMA 200
$9.72
Avg. Vol 10D
1.56M
Avg. Vol 30D
2.05M
Avg. Vol 90D
4.46M
Relative Vol
0.38
26.47M
0.4200%
2,500,000
292
Jan 3, 2024 · 1-for-80 (reverse)
TENX Profile

tenax therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.

TENX Performance
PeriodPriceDateChangeBeta
1W1.802026-11-02-6.39%1.883
1M1.872026-10-09-9.89%2.172
3M1.382026-08-10+22.55%1.889
6M11.662026-05-08-85.55%1.089
1Y6.992025-11-10-75.89%1.101
2Y4.742024-11-08-64.45%—
5Y2,368.002021-11-09-99.93%0.509
TENX Stock Summary

Tenax Therapeutics, Inc. (NASDAQ:TENX) stock price today is $1.69, and today's volume is 789,279. TENX is up 3.374% today. The 30 day average volume is 2.05M. TENX market cap is $76.73M with 45.54M shares outstanding.